Spatial methods for event reconstruction in CLEAN

In CLEAN (Cryogenic Low Energy Astrophysics with Noble gases), a proposed neutrino and dark matter detector, background discrimination is possible if one can determine the location of an ionizing radiation event with high accuracy. We simulate ionizing radiation events that produce multiple scintillation photons within a spherical detection volume filled with liquid neon. We estimate the radial location of a particular ionizing radiation event based on the observed count data corresponding to that event. The count data are collected by detectors mounted at the spherical boundary of the detection volume. We neglect absorption, but account for Rayleigh scattering. To account for wavelength-shifting of the scintillation light, we assume that photons are absorbed and re-emitted at the detectors. Here, we develop spatial Maximum Likelihood methods for event reconstruction, and study their performance in computer simulation experiments. We also study a method based on the centroid of the observed count data. We calibrate our estimates based on training data

Demonstration of photomultiplier tube operation at 29 K

We describe measurements of gain, dark current, and quantum efficiency obtained while cooling a Hamamatsu R5912-02-MOD photomultiplier tube from room temperature to 29 K. We found that the PMT operated normally down to 29 K, with a reduced gain and quantum efficiency at the lowest temperatures. Furthermore, we found that the dark count rate increased as the temperature decreased. We conclude that these PMTs appear to be adequate for the requirements of the CLEAN experiment.Comment: 3 pages, 5 figure

Measurement of scintillation efficiency for nuclear recoils in liquid argon

The scintillation light yield of liquid argon from nuclear recoils relative to electronic recoils has been measured as a function of recoil energy from 10 keVr up to 250 keVr at zero electric field. The scintillation efficiency, defined as the ratio of the nuclear recoil scintillation response to the electronic recoil response, is 0.25±0.01+0.01 (correlated) above 20 keVr. © 2012 American Physical Society

Dark sectors 2016 Workshop: community report

This report, based on the Dark Sectors workshop at SLAC in April 2016, summarizes the scientific importance of searches for dark sector dark matter and forces at masses beneath the weak-scale, the status of this broad international field, the important milestones motivating future exploration, and promising experimental opportunities to reach these milestones over the next 5-10 years

Measurement of Scintillation Efficiency for Nuclear Recoils in Liquid Argon

The scintillation light yield of liquid argon from nuclear recoils relative to electronic recoils has been measured as a function of recoil energy from 10 keVr up to 250 keVr at zero electric field. The scintillation efficiency, defined as the ratio of the nuclear recoil scintillation response to the electronic recoil response, is 0.25 ± 0.01 + 0.01 (correlated) above 20 keVr

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication.

Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing amount of resources in the United States health care system. Overall rates of intervention for PAD have been rising steadily in recent years. Changing demographics, evolution of technologies, and an expanding database of outcomes studies are primary forces influencing clinical decision making in PAD. The management of PAD is multidisciplinary, involving primary care physicians and vascular specialists with varying expertise in diagnostic and treatment modalities. PAD represents a broad spectrum of disease from asymptomatic through severe limb ischemia. The Society for Vascular Surgery Lower Extremity Practice Guidelines committee reviewed the evidence supporting clinical care in the treatment of asymptomatic PAD and intermittent claudication (IC). The committee made specific practice recommendations using the GRADE (Grades of Recommendation Assessment, Development and Evaluation) system. There are limited Level I data available for many of the critical questions in the field, demonstrating the urgent need for comparative effectiveness research in PAD. Emphasis is placed on risk factor modification, medical therapies, and broader use of exercise programs to improve cardiovascular health and functional performance. Screening for PAD appears of unproven benefit at present. Revascularization for IC is an appropriate therapy for selected patients with disabling symptoms, after a careful risk-benefit analysis. Treatment should be individualized based on comorbid conditions, degree of functional impairment, and anatomic factors. Invasive treatments for IC should provide predictable functional improvements with reasonable durability. A minimum threshold of a \u3e 50% likelihood of sustained efficacy for at least 2 years is suggested as a benchmark. Anatomic patency (freedom from restenosis) is considered a prerequisite for sustained efficacy of revascularization in IC. Endovascular approaches are favored for most candidates with aortoiliac disease and for selected patients with femoropopliteal disease in whom anatomic durability is expected to meet this minimum threshold. Conversely, caution is warranted in the use of interventions for IC in anatomic settings where durability is limited (extensive calcification, small-caliber arteries, diffuse infrainguinal disease, poor runoff). Surgical bypass may be a preferred strategy in good-risk patients with these disease patterns or in those with prior endovascular failures. Common femoral artery disease should be treated surgically, and saphenous vein is the preferred conduit for infrainguinal bypass grafting. Patients who undergo invasive treatments for IC should be monitored regularly in a surveillance program to record subjective improvements, assess risk factors, optimize compliance with cardioprotective medications, and monitor hemodynamic and patency status. Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved